Search Results - "Jirka, T"

Guided optimization of fluid status in haemodialysis patients by Machek, Petr, Jirka, Tomas, Moissl, Ulrich, Chamney, Paul, Wabel, Peter

“…Background. Achieving normohydration remains a non-trivial issue in haemodialysis therapy. Guiding the haemodialysis patient on the path between fluid overload…”
Get full text

Mortality risk for patients receiving hemodiafiltration versus hemodialysis by Jirka, T., Cesare, S., Di Benedetto, A., Perera Chang, M., Ponce, P., Richards, N., Tetta, C., Vaslaky, L.

Get full text

Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload by Wabel, Peter, Moissl, Ulrich, Chamney, Paul, Jirka, Tomas, Machek, Petr, Ponce, Pedro, Taborsky, Petr, Tetta, Ciro, Velasco, Nestor, Vlasak, Jiri, Zaluska, Wojciech, Wizemann, Volker

“…Background. Hypertension and fluid overload (FO) are well-recognized problems in the chronic kidney disease (CKD) population. While the prevalence of…”
Get full text

Hémodialyse chronique avec concentré acide au citrate : absence d’impact négatif sur la mortalité by Chazot, C., Neri, L., Bellocchio, F., Jean, G., Martial, L., Attaf, D., Jirka, T., Kircelli, F., Stuard, S., Canaud, B.

“…Récemment l’innocuité du dialysat avec concentré acide au citrate (CACi) a été mise en cause. Nous rapportons ici une analyse de mortalité des patients…”
Get full text

NEW DIALYSIS TECHNIQUES by Rocco, M., Daugirdas, J., Greene, T., Lockridge, R., Chan, C., Pierratos, A., Lindsay, R., Larive, B., Chertow, G., Beck, G., Eggers, P., Kliger, A., Laville, M., Dorval, M., Fort Ros, J., Fay, R., Cridlig, J., Nortier, J. L., Juillard, L., D bska- lizie , A., Fernandez Lorente, L., Thibaudin, D., Franssen, C. F., Schulz, M., Moureau, F., Loughraieb, N., Rossignol, P., Kliger, A. S., Chertow, G. M., Levin, N. W., Beck, G. J., Daugirdas, J. T., Eggers, P. W., Rocco, M. V., Marcelli, D., Jirka, T., Merello, J. I., Ponce, P., Ladanyi, E., Di Benedetto, A., Rosenberger, J., Stuard, S., Scholz, C., Canaud, B.

Get full text

Anaemia in CKD 5D

Get full text

Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy by Merta, M, Sobotová, D, Zahálková, J, Bitterová, Z, Jirka, T, Knetl, P, Kopenec, J, Suchanová, J, Vlasák, J

“…Treatment of anaemia of renal origin by recombinant erythropoietin (EPO) is well established and is considered to be an integral part of therapy in patients…”
Get more information